Company Filing History:
Years Active: 2018
Title: Vijay Kumar Kyama: Innovator in Pharmaceutical Compositions
Introduction
Vijay Kumar Kyama is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing stable compositions for compounds that are susceptible to hydrolysis. His work is essential for enhancing the efficacy and stability of pharmaceutical products.
Latest Patents
Vijay Kumar Kyama holds a patent for a process titled "Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis." This invention outlines a method that includes the addition of pharmaceutically acceptable lyophilization excipients, the use of organic solvents, and specific temperature controls to create stable pharmaceutical formulations. The process aims to ensure the stability of compounds that are prone to hydrolysis, which is crucial for their effectiveness.
Career Highlights
Vijay Kumar Kyama is currently employed at Fresenius Kabi Oncology Limited, where he continues to innovate in the pharmaceutical sector. His expertise in the preparation of stable compositions has positioned him as a valuable asset to his organization.
Collaborations
Some of his coworkers include Dhiraj Khattar and Rajesh Khanna, who contribute to the collaborative environment at Fresenius Kabi Oncology Limited. Their combined efforts enhance the research and development capabilities of the company.
Conclusion
Vijay Kumar Kyama's contributions to pharmaceutical innovations demonstrate his commitment to improving drug stability and efficacy. His patent reflects a significant advancement in the field, showcasing his role as a key inventor in the industry.